PharmaShots Weekly Snapshot (July 22 ' 26, 2019)
1.Epizyme Reports FDA's Acceptance of NDA for Tazemetostat to Treat Epithelioid Sarcoma
Published: Jul 25, 2019 | Tags: Epizyme, Reports, FDA, Acceptance, NDA, Tazemetostat, Treat, Epithelioid Sarcoma
Published: Jul 26, 2019 | Tags: Roche, Tecentriq, Receives, EU, CHMP, Recommendation, Approval, 1L, Therapy, Extensive-Stage Small Cell Lung Cancer
Published: Jul 26, 2019 | Tags: BMS, Triple Regimen, Receives, Positive, CHMP, Recommendation, Approval, Treat, R/R, Multiple Myeloma, Europe
4. Janssen Reports Results of Ponesimod in P-III OPTIMUM Study for Relapsing Multiple Sclerosis
Published: Jul 25, 2019 | Tags: Janssen, Reports, Results, Ponesimod, P-III, OPTIMUM, Study, Relapsing, Multiple Sclerosis
Published: Jul 25, 2019 | Tags: Boehringer, Ofev, nintedanib, Receives, FDA, Advisory, Committee, Recommendation, Systemic Sclerosis Associated ILD
Published: Jul 25, 2019 | Tags: Sanofi, Enter, Exclusive, License, Agreement, Verastem Oncology, Develop, Commercialize, Copiktra, duvelisib, Oncology, Indications6
Published: Jul 24, 2019 | Tags:Regenxbio, Signs, Exclusive, Development, Commercialization, Agreement, Neurimmune, AAV Gene Therapies, Targeting, Neurodegenerative Diseases
8. Allergan Voluntary Recalls Worldwide BIOCELL Textured Breast Implants and Tissue Expanders
Published: Jul 24, 2019 | Tags: Allergan, Voluntary, Worldwide, Recalls, BIOCELL, Textured Breast Implants, Tissue Expanders
9. Celgene Reports Update on its Collaboration with Jounce Therapeutics
Published: Jul 23, 2019 | Tags: Celgene, Reports, Update, Collaboration, Jounce Therapeutics
Published: Jul 24, 2019 | Tags: BMS, Reports, Results, Opdivo, nivolumab, + Yervoy, ipilimumab, P-III, CheckMate -227 Part 1a, Study, 1L, Non-Small Cell Lung Cancer
Published: Jul 24, 2019 | Tags: Eli Lilly, Baqsimi, glucagon, 3mg, Nasal Powder, Receives, FDA, Approval, Treatment, Severe, Hypoglycemia
12. Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine
Published: Jul 23, 2019 | Tags: Synapse, Signs, Agreement, Pfizer, Oncology, Precision Medicine13
Published: Jul 24, 2019 | Tags: Celgene, Partners, Multiple Sclerosis Association of America, Bring, MS MindShift, Brain Bulb Hot Air Balloon, Raise, Awareness, Multiple Sclerosis, Brain Health
Published: Jul 23, 2019 | Tags: Gilead, Reports, Updated, Results, Descovy, P-III, DISCOVER, Study, Pre-Exposure Prophylaxis, HIV
Published: Jul 23, 2019 | Tags: Medtronic, Solicits, US FDA, Non-Adjunctive Labeling, Approval, MiniMed 670G, Insulin Pump Sensor
16. Ligand to Acquire Ab Initio Biotherapeutics for its Antigen Technology
Published: Jul 23, 2019 | Tags: Ligand, Acquire, Ab Initio Biotherapeutics, Antigen Technology
17. Samsung Bioepis' Hadlima (biosimilar, adalimumab) Receives FDA's Approval for Autoimmune Diseases
Published: Jul 24, 2019 | Tags: Samsung Bioepis, Hadlima, biosimilar, adalimumab, Receives, FDA, Approval, Autoimmune Diseases
18. Pfizer's Ruxience (biosimilar, rituximab) Receives FDA's Approval for Cancer and Autoimmune Diseases
Published: Jul 23, 2019 | Tags: Pfizer, Ruxience, rituximab, biosimilar, Receives, FDA, Approval, Cancer, Autoimmune Diseases
Published: Jul 23, 2019 | Tags: Chiasma, Reports, Results, Mycapssa, octreotide, P-III, CHIASMA OPTIMAL, Study, Maintenance Therapy, Acromegaly
Published: Jul 23, 2019 | Tags: Merck, Eisai, Keytruda, pembrolizumab, Lenvima, lenvatinib, Receive, FDA, Third, Breakthrough Therapy Designation, 1L, Therapy, Hepatocellular Carcinoma
Published: Jul 22, 2019 | Tags: AstraZeneca, Reports, Inclusion, Overall Survival, Data, Labelling, Imfinzi, durvalumab, US
22. ViiV Healthcare Reports Results of Fostemsavir in P-III BRIGHTE Study for HIV-1 infection
Published: June 22, 2019 | Tags: ViiV Healthcare, Reports, Results, Fostemsavir, P-III, BRIGHTE, Study, HIV-1 infection
Published: Jul 23, 2019 | Tags: Sanofi, Signs, Exclusive Agreement, Roche, OTC Rights, Tamiflu, oseltamivir phosphate, US
Published: Jul 22, 2019 | Tags: Baxter, Myxredlin, Ready-To-Use Insulin, IV Infusion, Receives, FDA, Approval, Diabetes Mellitus
Published: Jul 22, 2019 | Tags: Gilead, Signs, Exclusive, Worldwide, License, Agreement, Durect, HIV, Hepatitis B, Products
Published: Jul 22, 2019 | Tags: Medtronic, Collaborates, Viz.ai, Facilitate, Adoption, AI, Software, Stroke Centers, US
Published: Jul 22, 2019 | Tags: Takeda, Reports, Results, Entyvio, vedolizumab SC, P-III, VISIBLE 2, Study, Moderately, Severely, Active, Crohn's Disease
Published: Jul 19, 2019 | Tags: Celgene, Otezla, apremilast, Receives, FDA, Approval, Oral Ulcers, Behçet's Disease
29. Sandoz Reports Patient Enrollment in P-I/III ROSALIA Study of Proposed Biosimilar Denosumab for Postmenopausal Osteoporosis
Published: Jul 22, 2019 | Tags: Sandoz, Reports, Patient Enrollment, P-I/III, ROSALIA, Study, Proposed Biosimilar Denosumab, Osteoporosis
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com